InflaRx NV (IFRX)
2.08
+0.04
(+1.96%)
USD |
NASDAQ |
Nov 21, 14:35
InflaRx Market Cap: 122.48M for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 20, 2024 | 120.12M |
| November 19, 2024 | 113.06M |
| November 18, 2024 | 102.46M |
| November 15, 2024 | 114.82M |
| November 14, 2024 | 119.53M |
| November 13, 2024 | 100.69M |
| November 12, 2024 | 88.91M |
| November 11, 2024 | 90.09M |
| November 08, 2024 | 91.86M |
| November 07, 2024 | 88.91M |
| November 06, 2024 | 90.09M |
| November 05, 2024 | 94.21M |
| November 04, 2024 | 91.86M |
| November 01, 2024 | 93.04M |
| October 31, 2024 | 91.27M |
| October 30, 2024 | 92.45M |
| October 29, 2024 | 92.15M |
| October 28, 2024 | 92.45M |
| October 25, 2024 | 92.45M |
| October 24, 2024 | 94.21M |
| October 23, 2024 | 87.74M |
| October 22, 2024 | 90.68M |
| October 21, 2024 | 90.09M |
| October 18, 2024 | 93.62M |
| October 17, 2024 | 91.27M |
| Date | Value |
|---|---|
| October 16, 2024 | 88.91M |
| October 15, 2024 | 87.15M |
| October 14, 2024 | 88.32M |
| October 11, 2024 | 88.91M |
| October 10, 2024 | 85.97M |
| October 09, 2024 | 87.15M |
| October 08, 2024 | 88.32M |
| October 07, 2024 | 90.09M |
| October 04, 2024 | 91.86M |
| October 03, 2024 | 91.86M |
| October 02, 2024 | 90.09M |
| October 01, 2024 | 88.91M |
| September 30, 2024 | 90.09M |
| September 27, 2024 | 92.45M |
| September 26, 2024 | 90.68M |
| September 25, 2024 | 89.50M |
| September 24, 2024 | 90.68M |
| September 23, 2024 | 87.15M |
| September 20, 2024 | 91.27M |
| September 19, 2024 | 89.50M |
| September 18, 2024 | 85.38M |
| September 17, 2024 | 84.79M |
| September 16, 2024 | 85.38M |
| September 13, 2024 | 84.20M |
| September 12, 2024 | 84.79M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
34.52M
Minimum
Jun 24 2022
300.89M
Maximum
May 01 2023
129.15M
Average
114.32M
Median
Dec 01 2020
Market Cap Benchmarks
| Affimed NV | 43.77M |
| BioNTech SE | 25.63B |
| Immatics NV | 931.07M |
| CureVac NV | 569.82M |
| ATAI Life Sciences NV | 255.06M |
Market Cap Related Metrics
| PS Ratio | 663.61 |
| Price to Book Value | 1.680 |
| Price | 2.08 |
| Earnings Yield | -51.66% |